The aim of the present study was to differentially determine quality of lif
e (QOL) in patients with end-stage renal disease (ESRD) after successful ki
dney transplantation (RT, Group A) compared with ESRD patients on a waiting
list for RT (Group B), and with healthy controls (Group C) because opinion
s vary as to which treatment modality can best assure ESRD-patients a high
QOL.
Groups A, B and C each consisted of 149 persons, matched for age and gender
. The Munich Quality of Life Dimensions List (MLDL) was used to measure glo
bal aspects of QOL. Distinct aspects of QOL were investigated by the Brief
Symptom Inventory (BSI) and the Questionnaire for Social Support (K-22).
Groups A and C reported similar QOL, which was significantly higher than in
group B (p <.0001). This was particularly true for the physical and psycho
logical status and daily activities, but not for the social situation. Grou
ps A and B reported similar social support, which was significantly lower t
han in group C (p <.006). Both ESRD groups reported higher satisfaction wit
h social support than healthy controls (p <.0001).
Successful RT not only improved distinct aspects of QOL in patients with ES
RD, but even put them on par with healthy controls regarding physical and p
sychological QOL.
Lower social support and higher satisfaction with social support in both gr
oups of ESRD patients should be evaluated further. From a clinical viewpoin
t, the improvement of physical and psychological aspects of QOL in RT patie
nts is impressive; but more attention should be paid to constantly low soci
al support in this group of patients. International multicenter longitudina
l studies to investigate QOL in ESRD patients under different treatments ar
e necessary.